These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 11851944)

  • 1. Massive haemolysis in a group A recipient of a group O peripheral blood stem cell allogeneic transplant.
    Tiplady CW; Fitzgerald JM; Jackson GH; Conn JS; Proctor SJ
    Transfus Med; 2001 Dec; 11(6):455-8. PubMed ID: 11851944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Massive immune haemolysis after allogeneic peripheral blood stem cell transplantation with minor ABO incompatibility.
    Bolan CD; Childs RW; Procter JL; Barrett AJ; Leitman SF
    Br J Haematol; 2001 Mar; 112(3):787-95. PubMed ID: 11260085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed massive immune hemolysis mediated by minor ABO incompatibility after allogeneic peripheral blood progenitor cell transplantation.
    Salmon JP; Michaux S; Hermanne JP; Baudoux E; Gérard C; Sontag-Thull D; Fillet G; Beguin Y
    Transfusion; 1999 Aug; 39(8):824-7. PubMed ID: 10504116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early and fatal immune haemolysis after so-called 'minor' ABO-incompatible peripheral blood stem cell allotransplantation.
    Oziel-Taieb S; Faucher-Barbey C; Chabannon C; Ladaique P; Saux P; Gouin F; Gastaut JA; Maraninchi D; Blaise D
    Bone Marrow Transplant; 1997 Jun; 19(11):1155-6. PubMed ID: 9193761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe immune hemolysis after minor ABO-mismatched allogeneic peripheral blood progenitor cell transplantation occurs more frequently after nonmyeloablative than myeloablative conditioning.
    Worel N; Greinix HT; Keil F; Mitterbauer M; Lechner K; Fischer G; Mayr W; Höcker P; Kalhs P
    Transfusion; 2002 Oct; 42(10):1293-301. PubMed ID: 12423513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Massive hemolysis following allogeneic peripheral blood stem cell transplantation with minor ABO incompatibility].
    Ishiyama M; Iwabe K; Hida M; Okamura T; Yoshinaga K; Hidai H; Kobayashi S; Sameshima Y; Mori N; Teramura M; Masuda M; Motoji T; Mizoguchi H
    Rinsho Ketsueki; 2002 Jun; 43(6):477-81. PubMed ID: 12134705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ABO compatibility and acute graft-versus-host disease following allogeneic bone marrow transplantation.
    Bacigalupo A; Van Lint MT; Occhini D; Margiocco M; Ferrari G; Pittaluga PA; Frassoni F; Peralvo J; Lercari G; Carubia F
    Transplantation; 1988 Jun; 45(6):1091-4. PubMed ID: 3289150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemolysis of transfused group O red blood cells in minor ABO-incompatible unrelated-donor bone marrow transplants in patients receiving cyclosporine without posttransplant methotrexate.
    Gajewski JL; Petz LD; Calhoun L; O'Rourke S; Landaw EM; Lyddane NR; Hunt LA; Schiller GJ; Ho WG; Champlin RE
    Blood; 1992 Jun; 79(11):3076-85. PubMed ID: 1586749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Massive immune hemolysis after non-myeloablative allogeneic peripheral blood stem cell transplantation with minor ABO-incompatibility.
    Noborio K; Muroi K; Izumi T; Toshima M; Kawano-Yamamoto C; Otsuki T; Nagai T; Komatsu N; Ozawa K
    Leuk Lymphoma; 2003 Feb; 44(2):357-9. PubMed ID: 12688358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transient hemolysis due to anti-D and anti-A
    Bailén R; Kwon M; Pérez-Corral AM; Pascual C; Buño I; Balsalobre P; Serrano D; Gayoso J; Díez-Martín JL; Anguita J
    Transfusion; 2017 Oct; 57(10):2355-2358. PubMed ID: 28703860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engraftment of early erythroid progenitors is not delayed after non-myeloablative major ABO-incompatible haematopoietic stem cell transplantation.
    Maciej Zaucha J; Mielcarek M; Takatu A; Little MT; Gooley T; Baker J; Maloney DG; Sandmaier BM; Maris M; Chauncey T; Storb R; Torok-Storb B
    Br J Haematol; 2002 Dec; 119(3):740-50. PubMed ID: 12437653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe immune haemolysis in a group A recipient of a group O red blood cell unit.
    Barjas-Castro ML; Locatelli MF; Carvalho MA; Gilli SO; Castro V
    Transfus Med; 2003 Aug; 13(4):239-41. PubMed ID: 12880395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Posttransplant immune-mediated hemolysis.
    Sokol RJ; Stamps R; Booker DJ; Scott FM; Laidlaw ST; Vandenberghe EA; Barker HF
    Transfusion; 2002 Feb; 42(2):198-204. PubMed ID: 11896335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Massive delayed hemolysis following peripheral blood stem cell transplantation with minor ABO incompatibility.
    Laurencet FM; Samii K; Bressoud A; Tajeddin M; Easton J; Stelling MJ; Chapuis B
    Hematol Cell Ther; 1997 Jun; 39(3):159-62. PubMed ID: 9262993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonmyeloablative peripheral blood stem cell transplant for T-cell prolymphocytic leukaemia complicated by fulminant haemolysis and acute renal failure at engraftment secondary to minor ABO incompatibility.
    Curtin NJ; Schwarer AP
    Clin Lab Haematol; 2005 Jun; 27(3):206-8. PubMed ID: 15938729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Passenger lymphocyte syndrome in ABO and Rhesus D minor mismatched liver and kidney transplantation: A prospective analysis.
    ElAnsary M; Hanna MO; Saadi G; ElShazly M; Fadel FI; Ahmed HA; Aziz AM; ElSharnouby A; Kandeel MM
    Hum Immunol; 2015 Jun; 76(6):447-52. PubMed ID: 25842056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical features and risk factors of pure red cell aplasia following major ABO-incompatible allogeneic hematopoietic stem cell transplantation.
    Zhu KE; Li JP; Zhang T; Zhong J; Chen J
    Hematology; 2007 Apr; 12(2):117-21. PubMed ID: 17454192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pure red-cell aplasia following major and bi-directional ABO-incompatible allogeneic stem-cell transplantation: recovery of donor-derived erythropoiesis after long-term treatment using different therapeutic strategies.
    Helbig G; Stella-Holowiecka B; Wojnar J; Krawczyk M; Krzemien S; Wojciechowska-Sadus M; Markiewicz M; Wylezol I; Kopera M; Holowiecki J
    Ann Hematol; 2007 Sep; 86(9):677-83. PubMed ID: 17486341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinically significant anti-A(1) in a presumed ABO-identical hematopoietic stem cell transplant recipient: a case report.
    Jaben EA; Jacob EK; Tauscher C; D'Souza A; Hogan WJ; Stubbs JR
    Transfusion; 2013 Jan; 53(1):202-5. PubMed ID: 22574682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Passenger B-lymphocyte-induced severe hemolytic disease after allogeneic peripheral blood stem cell transplantation.
    Toren A; Dacosta Y; Manny N; Varadi G; Or R; Nagler A
    Blood; 1996 Jan; 87(2):843-4. PubMed ID: 8555513
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.